Company News
Connect Biopharma Completes Asthma Enrollment, Shares +8%
Connect Biopharma shares jumped about 8% after confirming enrollment completion for its Phase 2 Seabreeze STAT Asthma trial of rademikibart.
The company expects to finish COPD study enrollment this mo
